This study is in progress, not accepting new patients

Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)

a study on Chronic Lymphocytic Leukemia Leukemia

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Diego, California
Dates
study started
completion around
Principal Investigator
by Ariel Portera, DO

Description

Summary

This study will evaluate the feasibility of an 8-week vegan whole-food, plant-based dietary intervention in subjects with low risk CLL who are undergoing observation. Over the course of 8 weeks, participants will attend weekly group cooking classes via Zoom lead by a RD. Participants will also attend weekly individual meetings with a health coaches to assist with adherence to the dietary intervention.

Official Title

Feasibility of a Whole-Food, Plant-Based Dietary Intervention for Patients With Low-Risk Chronic Lymphocytic Leukemia

Keywords

Chronic Lymphocytic Leukemia Stage A(0), whole-food plant-based diet, CLL, Leukemia, Lymphoid Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Whole-food, plant-based diet

Eligibility

You can join if…

Open to people ages 18 years and up

  • Patients who have a diagnosis of low-risk CLL according to the modified Rai staging criteria for a minimum of 12 months and are currently undergoing observation.
  • Access to a computer or tablet and Zoom.

You CAN'T join if...

  • Have active disease and are currently receiving pharmacologic treatment for CLL
  • Have previously received treatment for CLL
  • Are currently following a vegan or vegetarian diet
  • A previous or current diagnosis of disordered eating including anorexia, bulimia, binge eating disorder or avoidant/restrictive food intake disorder.
  • A diagnosis of Type 1 diabetes
  • A diagnosis of Insulin dependent type 2 diabetes
  • Currently pregnant or planning to become pregnant

Location

  • UC San Diego
    San Diego California 92093 United States

Lead Scientist at UCSD

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Diego
ID
NCT06377501
Study Type
Interventional
Participants
About 19 people participating
Last Updated